Democrats escalate probe of Trump admin drug pricing deals
Summary
Congressional Democrats are pressing pharmaceutical companies to disclose unredacted details of their “most favored nation” agreements with the Trump administration. The effort is led by lawmakers who could take on health policy leadership roles in Congress next year.Key Facts
- Democrats are demanding that drugmakers disclose the full terms of their agreements with the administration.
- The agreements are described as “most favored nation” deals.
- The request comes from Democrats who may lead health policy work in Congress next year.
- Democratic Rep. Frank Pallone Jr. of New Jersey is named as involved.
- The article excerpt does not provide further details about the deals or the companies involved.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
